Novartis India MD Sanjay Murdeshwar resigns
Novartis India has said its vice chairman and managing director Sanjay Murdeshwar has resigned. The company's board, at its meeting on Thursday, has accepted his resignation, the drug firm said in a regulatory filing.Murdeshwar in a letter "dated January 25, 2024, has tendered his resignation as director and employee of the company with effect from close of business hours of April 2,...
Novartis India has said its vice chairman and managing director Sanjay Murdeshwar has resigned. The company's board, at its meeting on Thursday, has accepted his resignation, the drug firm said in a regulatory filing.
In India, Novartis has had a significant footprint since 1947. The Company have two legal entities namely, Novartis Healthcare Private Limited (NHPL) and Novartis India Limited (NIL) employing about 10,000 people.
Its rich portfolio of both innovative and established medicines address various therapeutic needs: cardiovascular, eye care, immunology, metabolic, neuroscience, oncology, respiratory and organ transplant, to meet the medical needs of patients in India.
India is amongst a handful of countries in the world that have a broad Novartis footprint covering early research, drug development, technical operations, business services and commercial operations.
Original news source: https://www.ptinews.com/story/business/novartis-india-md-sanjay-murdeshwar-resigns/1241112
Read also: Novartis Gets CDSCO Panel nod to study antimalarial drug KLU156 with Coartem
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd